Hospitals today are drowning in paperwork. Behind every patient visit, there are layers of manual work: coding, billing, and admissions, often spread across outdated systems. Doctors and staff end up spending hours on admin instead of patient care.
That’s the problem Paris-based Parallel is trying to solve.
The company has raised $20 million (approx €17.3M) in a Series A round led by Index Ventures, with participation from Frst, YC, Hexa, and angels including Arthur Mensch and leaders from Pennylane.
Where will the $20M go?
The new funding will help Parallel scale its existing products and expand internationally.
It also plans to develop new AI agents to automate additional hospital processes and expand its team.
The long-term goal is clear: reduce administrative burden so healthcare professionals can focus more on patients.
What Parallel actually does?
Launched in 2025 by Paul Lafforgue and Chris Rydahl, Parallel is a software solution that builds AI agents to automate administrative tasks in hospitals.
“Because our technology runs on top of legacy systems rather than requiring deep integration, our agents can automate a wide range of administrative tasks in healthcare. That means less time and resources spent on cumbersome, manual processes,” said Paul Lafforgue, Parallel co-founder and CEO
Parallel automates this work with AI agents that operate directly inside hospital software. Instead of requiring hospitals to replace or integrate deeply with existing systems, Parallel runs as an AI layer on top of them, learning to use the software as a human would.
While traditional integrations into healthcare platforms can take 12 to 24 months, if they succeed at all, Parallel can be deployed in as little as a week. Parallel plans to expand into other hospital workflows like billing and admissions, where staff still rely heavily on manual data entry across multiple systems.
Less than a year after its $3.5 million seed round, Parallel’s AI agents are already live in dozens of public and private hospitals. That early adoption is one of the reasons investors are backing the company.
“The speed with which hospitals see the real impact… has been truly impressive,” said Julia Andre, partner at Index Ventures. She added that AI agents could reshape how hospitals operate across the entire patient lifecycle.
